Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 13, 2017
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancerMarzia Del Re, Caterina Vivaldi, Eleonora Rofi, et al.
Critical Reviews in Oncology/Hematology|April 29, 2020
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancersEleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatmentMarzia Del Re, Stefania Crucitta, Giuliana Restante, et al.
Journal of Medical Virology|April 20, 2019
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competenceLisa Macera, Pietro Giorgio Spezia, Chiara Medici, et al.
Critical Reviews in Oncology/Hematology|November 8, 2019
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancersEleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
Pharmacogenomics|December 7, 2018
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancerEleonora Rofi, Caterina Vivaldi, Marzia Del Re, et al.
Frontiers in Oncology|January 25, 2021
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung CancerFederico Cucchiara, Marzia Del Re, Simona Valleggi, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2019
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapyStefania Crucitta, Giuliana Restante, Marzia Del Re, et al.
British Journal of Cancer|November 7, 2018
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib responseMarzia Del Re, Paola Bordi, Eleonora Rofi, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Pageof 3